Today, as a result of medical research, eight out of 10 children will survive their cancer. But, unfortunately, nearly three children in Australia are still dying from this disease every week.
We believe this is three too many.
From the very beginning, our sole focus has been to cure all children with cancer and eliminate their suffering. While we are getting closer to this aim, there is so much more to do.
With the right investment in dedicated childhood cancer research, we believe we can and will cure childhood cancer in the foreseeable future; and improve the quality of life for survivors.
Most people don’t realise that childhood cancer is different from adult cancer – it occurs in different tissues and behaves differently, and therefore requires differently tailored treatments. Historically, large pharmaceutical companies generally haven’t focused their research on drug discoveries for childhood cancers, concentrating instead on the larger adult cancer market.
That makes our work vital. As the only independent research institute in Australia wholly dedicated to childhood cancer, it’s up to us to make sure that our discoveries are progressed into new treatments for kids as quickly as possible. And that is what drives us every day.
As we celebrate 30 years of dedicated medical research into childhood cancer, we are very excited to be at the forefront of a new era in childhood cancer treatment: personalised medicine.
We know a ‘one size fits all’ approach to treating children with cancer does not work, especially for those unfortunate enough to be diagnosed with the most aggressive cancers. This is why personalised medicine is the key to improving survival rates and giving children with cancer the best possible quality of life.
We are ideally positioned, through our close partnership with treating clinicians, to accelerate our personalised medicine program – which will maximise the likelihood of successful treatment outcomes by targeting the use of new and existing drugs most effectively to the biology of each child’s cancer.
Our community of children, parents, researchers, clinicians and supporters, across Australia and around the world, share our determination for success. We won’t stop until the job is done, and we know they won’t either.